[HTML][HTML] Knee osteoarthritis: epidemiology, pathogenesis, and mesenchymal stem cells: what else is new? An update
R Giorgino, D Albano, S Fusco, GM Peretti… - International journal of …, 2023 - mdpi.com
Osteoarthritis (OA) is a chronic disease and the most common orthopedic disorder. A vast
majority of the social OA burden is related to hips and knees. The prevalence of knee OA …
majority of the social OA burden is related to hips and knees. The prevalence of knee OA …
[HTML][HTML] NF-κB signaling pathways in osteoarthritic cartilage destruction
MC Choi, J Jo, J Park, HK Kang, Y Park - Cells, 2019 - mdpi.com
Osteoarthritis (OA) is a type of joint disease associated with wear and tear, inflammation,
and aging. Mechanical stress along with synovial inflammation promotes the degradation of …
and aging. Mechanical stress along with synovial inflammation promotes the degradation of …
Articular cartilage regeneration by activated skeletal stem cells
Osteoarthritis (OA) is a degenerative disease resulting in irreversible, progressive
destruction of articular cartilage. The etiology of OA is complex and involves a variety of …
destruction of articular cartilage. The etiology of OA is complex and involves a variety of …
[HTML][HTML] A plant-derived natural photosynthetic system for improving cell anabolism
P Chen, X Liu, C Gu, P Zhong, N Song, M Li, Z Dai… - Nature, 2022 - nature.com
Insufficient intracellular anabolism is a crucial factor involved in many pathological
processes in the body,. The anabolism of intracellular substances requires the consumption …
processes in the body,. The anabolism of intracellular substances requires the consumption …
Ice-inspired lubricated drug delivery particles from microfluidic electrospray for osteoarthritis treatment
Particle-based drug delivery systems have a demonstrated value in osteoarthritis treatment.
Research in this area trends to developing functional particles to improve the therapeutic …
Research in this area trends to developing functional particles to improve the therapeutic …
Anti‐friction MSCs delivery system improves the therapy for severe osteoarthritis
X Yan, B Yang, Y Chen, Y Song, J Ye, Y Pan… - Advanced …, 2021 - Wiley Online Library
Osteoarthritis (OA) is a musculoskeletal disorder disease affecting about 500 million people
worldwide and mesenchymal sem cells (MSCs) therapy has been demonstrated as a …
worldwide and mesenchymal sem cells (MSCs) therapy has been demonstrated as a …
Membranes for guided bone regeneration: a road from bench to bedside
P Aprile, D Letourneur… - Advanced healthcare …, 2020 - Wiley Online Library
Bone resorption can negatively influence the osseointegration of dental implants. Barrier
membranes for guided bone regeneration (GBR) are used to exclude nonosteogenic tissues …
membranes for guided bone regeneration (GBR) are used to exclude nonosteogenic tissues …
Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases
Therapeutic glucocorticoids have been widely used in rheumatic diseases since they
became available over 60 years ago. Despite the advent of more specific biologic therapies …
became available over 60 years ago. Despite the advent of more specific biologic therapies …
[HTML][HTML] Targeted and responsive biomaterials in osteoarthritis
J Li, H Zhang, Y Han, Y Hu, Z Geng, J Su - Theranostics, 2023 - ncbi.nlm.nih.gov
Osteoarthritis (OA) is a degenerative disease characterized by loss of articular cartilage and
chronic inflammation, involving multiple cellular dysfunctions and tissue lesions. The non …
chronic inflammation, involving multiple cellular dysfunctions and tissue lesions. The non …
Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis
Objective To evaluate the effectiveness and safety of viscosupplementation for pain and
function in patients with knee osteoarthritis. Design Systematic review and meta-analysis of …
function in patients with knee osteoarthritis. Design Systematic review and meta-analysis of …